AI in genomics market to reach $9,859.7 million by 2031, registering a CAGR of 40.6%
The AI in genomics market refers to the use of artificial intelligence (AI) and machine learning (ML) techniques to analyze and interpret genomic data.
Companies in the News
Financial General
Revolutionizing Autoimmune Disease Management: A Look into the Growing Therapeutics Market
Autoimmune diseases occur when the body's immune system attacks its own healthy tissues, leading to chronic inflammation and damage to various organs.
Global 5G Chipset Market Size Worth USD 300.88 Billion by 2032 | Forecast & CAGR 31.8%
The 5?? ?????????????? ???????????? covers a broad family of semiconductor components that enable 5G connectivity: modems (baseband), RF front-end components (RFIC, power amplifiers, transceivers), mmWave transceivers/antenna modules, system-on-chips (SoCs) that integrate application cores with 5G modems, and specialist ASICs/FPGAs for base station and infrastructure use.
Diverse Biotech Inc. Initiates Regulation D Private Placement to Fund Accelerated Development of new Antibiotic Class
Diverse Biotech Inc., a pioneering biopharmaceutical company dedicated to addressing significant unmet medical needs, today announced the initiation of a Regulation D Private Placement offering for accredited investors.
Saudi Arabia’s KFSHRC Reduces Emergency Department Boarding Time by 75%
King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has reduced the median emergency department boarding time from over 13 hours in 2023 to just 3.
Potentiate Ventures Invests in ConnectBooks as Eytan Wiener Joins to Transform eCommerce Accounting
Potentiate Ventures announced its investment in ConnectBooks, with founder Eytan Wiener also joining the company as Head of Growth. eCommerce sellers and their financial partners have long struggled with fragmented data and incomplete visibility across sales channels.
Antibody Production Market Outlook 2025–2035 | CAGR 11.2% & Market Trends
The antibody production market encompasses the manufacturing of monoclonal and polyclonal antibodies for therapeutic, diagnostic, and research applications.
◂Previous Page
Financial General Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Basin Energy Ltd (ASX:BSN) Completes Phase One Drilling and Expands Sybella-Barkly
- Deep Yellow Limited (ASX:DYL) Tumas Project Update
- Central Petroleum Limited (ASX:CTP) LOI Signed for New Drilling and Long-Term Gas Supply
- Beetaloo Energy Australia Limited (ASX:BTL) Reaches Carpentaria Pilot Project FID
- Beetaloo Energy Australia Limited (ASX:BTL) Final Approval for EP187 Appraisal Gas Sales
- State Gas Limited (ASX:GAS) Secured $3.2 million via Structured Loan Notes at a Premium
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Predicts Risk of DKD in Aboriginal Australians
- TempraMed Technologies Ltd. (CNSX:VIVI) Exclusive Commercial Distribution Agreement with Turkish Medical Device Supplier
- BPH Energy Limited (ASX:BPH) Chair's Address to Shareholders
- Proteomics International Laboratories Ltd (ASX:PIQ) US Medicare Sets Reimbursement Price for PromarkerD DKD Test
Social Media
